e-learning
resources
Madrid 2019
Tuesday, 01.10.2019
Multidrug resistance in nosocomial pneumonia: burden, magnitude and solution
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Improving antibiotic utilisation for nosocomial pneumonia
J. Rello (Barcelona, Spain)
Source:
International Congress 2019 – Multidrug resistance in nosocomial pneumonia: burden, magnitude and solution
Session:
Multidrug resistance in nosocomial pneumonia: burden, magnitude and solution
Session type:
Hot topic
Number:
3532
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
J. Rello (Barcelona, Spain). Improving antibiotic utilisation for nosocomial pneumonia. International Congress 2019 – Multidrug resistance in nosocomial pneumonia: burden, magnitude and solution
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Related content which might interest you:
Antibiotic management of nosocomial pneumonia in children
Source: Eur Respir J 2006; 28: Suppl. 50, 633s
Year: 2006
Hospital-acquired pneumonia: microbiological data and potential adequacy of antimicrobial regimens
Source: Eur Respir J 2002; 20: 432-439
Year: 2002
Antibiotic resistance and nosocomial pneumonia
Source: Eur Respir J 2005; 26: Suppl. 49, 641s
Year: 2005
Broad-spectrum antibiotic use and poor outcomes in community-onset pneumonia
Source: International Congress 2018 – Improving the outcomes of community-acquired pneumonia
Year: 2018
Determinants of prescription and choice of empirical therapy for hospital-acquired and ventilator-associated pneumonia
Source: Eur Respir J 2011; 37: 1332-1339
Year: 2011
Trends in empiric antimicrobial therapy and efficiency of care for community-acquired pneumonia in hospitalized Belarussian patients
Source: Annual Congress 2007 - Antibiotic treatment in community-acquired pneumonia
Year: 2007
Importance of appropriate initial antibiotic therapy and de-escalation in the treatment of nosocomial pneumonia
Source: Eur Respir Rev 2007; 16: 33-39
Year: 2007
Challenges in the management of hospital-acquired pneumonia including ventilator-associated pneumonia
Source: ERS Course 2018 - Respiratory Infections
Year: 2018
Optimising the duration of antibiotic therapy for ventilator-associated pneumonia
Source: Eur Respir Rev 2007; 16: 40-44
Year: 2007
Determinants of performance of indicators on antibiotic use in community-acquired pneumonia (CAP) at hospitals
Source: Eur Respir J 2005; 26: Suppl. 49, 638s
Year: 2005
Guideline-concordant therapy and outcomes in healthcare-associated pneumonia
Source: Eur Respir J 2011; 38: 878-887
Year: 2011
Optimizing treatment for community-acquired pneumonia through a care bundle
Source: International Congress 2019 – Prognosis in bacterial and viral pneumonia
Year: 2019
Pharmacokinetic optimisation of β-lactams for the treatment of ventilator-associated pneumonia
Source: Eur Respir Rev 2007; 16: 45-49
Year: 2007
Antibiotic treatment for nosocomial pneumonia
Source: ISSN=1025-448x, ISBN=1-904097-32-4, page=211
Year: 2004
VAP: approach to therapy
Source: Eur Respir Mon 2011; 53: 36-47
Year: 2011
The cost of inpatient care in community-acquired pneumonia
Source: Eur Respir J 2005; 26: Suppl. 49, 258s
Year: 2005
Oral antibiotics prior to hospitalisation for community-acquired pneumonia
Source: Eur Respir J 2008; 31: 478-479
Year: 2008
Preventing nosocomial pneumonia in intensive care unit. Something new?
Source: Annual Congress 2007 - Preventing nosocomial pneumonia in the intensive care unit. Something new?
Year: 2007
Ventilator-associated pneumonia due to colistin susceptible-only microorganisms
Source: Eur Respir J 2007; 30: 307-313
Year: 2007
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept